Is AI the Cancer-Fighting Tool We've been Waiting For?
As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against this complex disease.
Source: newsweek.com
📰 Jeff Bluestone News
Jeff Bluestone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jeff Bluestone. Real-time updates on events, politics, business and more.
Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer
Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointments of Joseph R. Arron, M.D., Ph.D., as Chief...
Stanford University United States San Francisco South San Francisco Sonoma Biotherapeutics Fred Ramsdell
Source: lelezard.com
Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone paymentTARRYTOWN,... | March 28, 2023
United States Alexandra Bowie Sonoma Biotherapeutics Georged Yancopoulos Regeneron Velocisuite Sonoma Bio
Source: marketscreener.com
Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone payment ... | March 28, 2023
United States Sonoma Bio Georged Yancopoulos Sonoma Biotherapeutic Sonoma Biotherapeutics Regeneron Velocisuite
Source: marketscreener.com
Cimeio Therapeutics Raises $50M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A - read this article along with other careers information, tips and advice on BioSpace
United States Dana Farber Cancer Institute Stanford University University Of California San Francisco Thomas Winkler Thomas Fuchs
Source: biospace.com
James P. Allison – Biographical - NobelPrize.org
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation".
Source: nobelprize.org
Meet the Carousing, Harmonica-Playing Texan Who Won a Nobel for his Cancer Breakthrough
This essay is part of a series on cultural, scientific and esoteric matters. Jim Allison is an iconoclastic scientist who toiled in obscurity for years. Then he helped crack a mystery that may save millions of lives: Why doesn’t the immune system attack cancer? Chance favors the prepared mind. —Louis Pasteur This material was first published by WIRED magazine on 10.22.2018 ADAPTED FROM THE book The Breakthrough: Immunotherapy and the Race to Cure Cancer, JAMES ALLISON LOOKS like a cro...
Source: greanvillepost.com